Editas Medicine, Inc. (EDIT) financial statements and ratios from SEC XBRL: revenue $40.52M (TTM), net margin -395.0%, revenue growth 25.4% YoY. Income statement, balance sheet, cash flow, and valuation. First-party data.
| Revenue (TTM) | $40.52M |
| Net Margin | -395.0% |
| Revenue Growth (YoY) | 25.4% |
| EPS Growth (YoY) | -37.5% |
| FCF Growth (YoY) | -24.3% |
| Price / Book | 4.52 |
| Price / Sales | 18.97 |
| FCF Yield | -48.0% |
| Altman Z-Score | -12.94 (distress) |
| Sector P/E (Healthcare) | 21.7 |
EDIT overview · EDIT earnings · EDIT KPIs · EDIT investor relations · EDIT ownership · EDIT peers · EDIT filings
Data sourced from U.S. SEC EDGAR XBRL filings. Not personalized investment advice.